The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of body mass index and menopausal disorders during menopause on vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: A prospective multicenter cohort study of patient-reported outcomes.
Kaori Tane
No relevant relationships to disclose
Chiyomi Egawa
No relevant relationships to disclose
Shintaro Takao
No relevant relationships to disclose
Masaru Miyashita
No relevant relationships to disclose
Kazuhiko Yamagami
No relevant relationships to disclose
Masashi Baba
No relevant relationships to disclose
Shigetoshi Ichii
No relevant relationships to disclose
Muneharu Konishi
No relevant relationships to disclose
Yuichiro Kikawa
No relevant relationships to disclose
Junya Minohata
No relevant relationships to disclose
Toshitaka Okuno
No relevant relationships to disclose
Keisuke Miyauchi
No relevant relationships to disclose
Yasuo Miyoshi
Honoraria - AstraZeneca; Chugai Pharma; Taiho Pharmaceutical
Research Funding - AstraZeneca; Chugai Pharma; Novartis Pharma K.K.